Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
16
Unnamed facility
Lodz, Poland
Unnamed facility
Tarnów, Poland
Unnamed facility
Warsaw, Poland
Number of Subjects With AEs
To evaluate the safety and tolerability of Cat-PAD in paediatric subjects aged 5 to \<12 years.
Time frame: up to 36 weeks after start of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.